
Aflac Incorporated $AFL Shares Sold by Allianz SE

Allianz SE reduced its holdings in Aflac Incorporated by 34% in Q2, selling 4,722 shares and retaining 9,180 shares worth $968,000. Several other institutional investors also modified their holdings. Aflac's stock opened at $114.96, with a market cap of $60.25 billion. The company reported $1.07 EPS for the quarter and increased its quarterly dividend to $0.61 per share. Analysts have mixed ratings on Aflac, with a consensus target price of $110.50.
Allianz SE lessened its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 34.0% in the second quarter, according to its most recent filing with the SEC. The firm owned 9,180 shares of the financial services provider's stock after selling 4,722 shares during the quarter. Allianz SE's holdings in Aflac were worth $968,000 as of its most recent SEC filing.
- 4 Stocks Making New Highs Despite Market Weakness
Several other institutional investors and hedge funds also recently modified their holdings of AFL. Mid American Wealth Advisory Group Inc. acquired a new stake in Aflac in the second quarter worth about $26,000. Chilton Capital Management LLC bought a new stake in shares of Aflac during the 2nd quarter worth about $26,000. Whipplewood Advisors LLC lifted its stake in shares of Aflac by 1,526.7% in the 2nd quarter. Whipplewood Advisors LLC now owns 244 shares of the financial services provider's stock worth $26,000 after acquiring an additional 229 shares during the period. AlphaCore Capital LLC acquired a new stake in shares of Aflac in the 1st quarter worth approximately $28,000. Finally, Hilltop National Bank bought a new position in shares of Aflac in the second quarter valued at approximately $32,000. Institutional investors own 67.44% of the company's stock.
Aflac Stock Up 0.3%
Shares of Aflac stock opened at $114.96 on Friday. Aflac Incorporated has a 12-month low of $96.95 and a 12-month high of $115.45. The firm has a market capitalization of $60.25 billion, a PE ratio of 26.07, a price-to-earnings-growth ratio of 2.93 and a beta of 0.83. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.33. The stock's fifty day moving average is $109.57 and its 200-day moving average is $105.91.
- Pegasystems flies on AI decision and workflow automation platform
Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share for the quarter. The firm had revenue of $5.91 billion for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%. Equities analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Wednesday, February 18th will be given a dividend of $0.61 per share. This represents a $2.44 annualized dividend and a yield of 2.1%. The ex-dividend date is Wednesday, February 18th. This is a positive change from Aflac's previous quarterly dividend of $0.58. Aflac's dividend payout ratio is presently 30.29%.
- Insurance Stocks - Best Insurance Stocks to Buy Now
Aflac declared that its Board of Directors has authorized a share repurchase plan on Tuesday, August 12th that allows the company to repurchase 100,000,000 outstanding shares. This repurchase authorization allows the financial services provider to reacquire shares of its stock through open market purchases. Stock repurchase plans are often a sign that the company's board of directors believes its shares are undervalued.
Analysts Set New Price Targets
Several equities research analysts recently commented on AFL shares. Evercore ISI boosted their target price on Aflac from $110.00 to $111.00 and gave the stock an "underperform" rating in a report on Friday, November 7th. Wells Fargo & Company boosted their price objective on Aflac from $107.00 to $109.00 and gave the stock an "equal weight" rating in a research note on Friday, November 7th. JPMorgan Chase & Co. raised their target price on Aflac from $100.00 to $101.00 and gave the company a "neutral" rating in a research note on Wednesday, November 5th. Wall Street Zen raised Aflac from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. Finally, Piper Sandler set a $125.00 price target on shares of Aflac and gave the stock an "overweight" rating in a research report on Tuesday, October 7th. Three equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $110.50.
View Our Latest Report on AFL
Insider Activity at Aflac
In other Aflac news, EVP Frederic Jean Guy Simard sold 1,722 shares of the business's stock in a transaction on Thursday, November 6th. The shares were sold at an average price of $112.50, for a total transaction of $193,725.00. Following the sale, the executive vice president directly owned 1,364 shares of the company's stock, valued at $153,450. The trade was a 55.80% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm's stock in a transaction on Friday, November 7th. The stock was sold at an average price of $114.00, for a total value of $114,000.00. Following the completion of the sale, the director directly owned 23,615 shares of the company's stock, valued at approximately $2,692,110. This trade represents a 4.06% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders own 0.80% of the company's stock.
About Aflac
(Free Report)Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- dLocal Falls Despite Blowout Q3 Results—What Investors Are Missing
- What is the Shanghai Stock Exchange Composite Index?
- Ondas Holdings Signals a Rebound as Drone Demand Soars
- Election Stocks: How Elections Affect the Stock Market
- Disney’s 2026 Outlook Brightens Under Iger's Magic Touch
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Aflac Right Now?
Before you consider Aflac, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aflac wasn't on the list.
While Aflac currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

